The next step in clinical intervention programs.
Pharmacists should incorporate and modify existing clinical intervention programs to document pharmacists' effects on patient care and quality drug-therapy management. We have already demonstrated the pharmacist's role in drug cost savings through the intervention programs, and now QIP can assist us in taking the next step in providing quality patient care. If we endorse the principles of pharmaceutical care, we must assume the responsibility for documenting our value as pharmacists in managing drug therapy in patients. The clinical intervention programs will deemphasize the value of drug cost analysis and emphasize effects on patient-care outcome. We believe that facilitating positive patient outcomes will decrease overall health care costs. As managers, we must assist our pharmacists in endorsing this concept by developing our programs to show the maximum benefit of their efforts in the patient-care arena.
Catania
H F
HF
St. Joseph Medical Center, Stockton, CA.
Yee
W P
WP
Catania
P N
PN
D002140:California; D004282:Documentation; D004358:Drug Therapy / Q000592:standards; D004363:Drug Utilization; D006745:Hospital Bed Capacity, 300 to 499; D010348:Patient Care Team; D010595:Pharmacists; D010607:Pharmacy Service, Hospital / Q000592:standards*; D010606:Pharmacy and Therapeutics Committee; D011785:Quality Assurance, Health Care / Q000458:organization & administration*